Skip to main content
. 2015 Jul;43(7):928–935. doi: 10.1124/dmd.115.063271

TABLE 3.

Residual glucuronidation activity after treatment with inhibitors

Control incubations contained vehicle only (DMSO for diclofenac and sulfynpirazone, and methanol for hecogenin). Data represent means ± S.D. of duplicate determinations in a single experiment.

UGTs Residual Activity (% Control)
1 mM Sulfinpyrazone 200 µM Hecogenin 500 µM Diclofenac
UGT1A1 N.A. N.A. 14.5 ± 0.9
UGT1A3 65.9 ± 0.4 N.A. N.A.
UGT1A4 N.A. 0 N.A.
UGT1A6 N.A. N.A. 11.7 ± 0.9
UGT1A7 N.A. N.A. 0
UGT1A8 N.A. N.A. 0
UGT1A9 N.A. N.A. 20.3 ± 0.1
UGT1A10 N.A. N.A. 0
UGT2B4 N.A. N.A. 0
UGT2B7 N.A. N.A. 4.5 ± 0.0
UGT2B15 N.A. N.A. 8.5 ± 0.1
UGT2B17 N.A. N.A. 0

N.A., not applicable.